Genetically engineered salmon clears FDA import hurdle

Genetically engineered salmon is on its way to the United States.  Food and Drug Commissioner Scott Gottlieb announced Friday that he is canceling an import alert, the last barrier keeping the fish out of the country.  The manufacturer of AquAdvantage Salmon can now transport engineered salmon eggs to the company’s facility in Indiana, where it’s to be grown into full-sized salmon. It is the first animal with intentionally altered genes allowed to be sold for human consumption. 

The FDA concluded in 2015 that the fish is safe to eat.

AquAdvantage Salmon is designed to grow about twice as fast as regular farmed salmon. In Alaska, where wild salmon is a top export, the engineered product has been viewed as a threat, to both the environment and commerce.

Sen. Lisa Murkowski calls it “Frankenfish,” and says she’ll ramp up efforts to pass a more stringent labeling law.

But at the Alaska Seafood Marketing Institute, interim director Jeremy Woodrow is not panicking.

“You know, honestly, here at ASMI, we see that as just another farmed seafood product, and we’ve been competing against farmed salmon in the marketplace for several decades now.”

Farmed salmon is generally cheaper, but ASMI has pressed Alaska salmon as a quality brand, emphasizing that it is never farmed.

“Wild, natural, sustainable – those are attributes that really only apply to Alaska salmon, wild-harvested salmon and that sets us apart in the marketplace, and those are the attributes that we’ll continue to sell to customers.”

The U.S. Department of Agriculture approved rules in December that require the AquAdvantage fish to be labeled as “bioengineered,” but not necessarily in *words* written on the packaging. The requirement could be met with a QR code on the label that the consumer would scan with a smartphone, which would lead to a web page that contains the information.